N-Fmoc-N-(cyclohexylmethyl)-glycine incorporates a bulky cyclohexylmethyl group, enhancing hydrophobic character and steric rigidity. The residue alters local folding and modulates backbone flexibility. Researchers use it to design constrained peptide frameworks and examine hydrophobic clustering. Its protected form facilitates controlled incorporation into synthetic sequences.
CAT No: R2143
CAS No:1374785-49-5
Synonyms/Alias:N-Fmoc-N-(cyclohexylmethyl)-glycine;1374785-49-5;[(cyclohexylmethyl)[(9H-fluoren-9-ylmethoxy)carbonyl]amino]acetic acid;MFCD31696121;CS-0439231;F80979;2-[cyclohexylmethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]acetic acid;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More